SARS-CoV-2 Nucleocapsid Protein (D63G, R203M, D377Y), His Tag
SARS-CoV-2 Nucleocapsid Protein (D63G, R203M, D377Y), His Tag

Lane R: 2 μg of SARS-CoV-2 Nucleocapsid Protein (D63G, R203M, D377Y), His Tag, reducing(R)
> 90% as analyzed by SDS-PAGE

SARS-CoV-2 Nucleocapsid Protein (D63G, R203M, D377Y), His Tag

ELISA binding of SARS-CoV-2 Nucleocapsid Antibody (N338), mAb, mouse (GenScript, A02135) with SARS-CoV-2 Nucleocapsid Protein (D63G, R203M, D377Y), His Tag (GenScript, Z03732)

Coating antigen:
SARS-CoV-2 Nucleocapsid Protein (D63G, R203M, D377Y), His Tag (GenScript, Z03732), 1 μg/mL

SARS-CoV-2 Nucleocapsid Antibody (N338), mAb, mouse (GenScript, A02135) dilution start from 2 μg/ml

SARS-CoV-2 Nucleocapsid Protein (D63G, R203M, D377Y), His Tag

SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2), also known as 2019-nCoV, is a positive-sense single-stranded RNA virus. It caused coronavirus disease 2019 (COVID-19). Nucleocapsid Protein is the most abundant structural protein of the coronavirus which is associated with the nucleic acid. The sublineage B.1.617.2 has been redesignated as a "variant of concern" (VOC-21APR-02) in May 2021, which spreads more quickly than the original version of the virus.
Z03732
¥68,875.00

Ask us a question
Product Introduction
Species SARS-CoV-2
Protein Construction

Expressed with the mutations of D63G, R203M, D377Y.

N protein (Met 1 - Ala 419)
Accession # P0DTC9		 Poly-His
N-term C-term
Purity > 90% as analyzed by SDS-PAGE
Biological Activity SARS-CoV-2 Nucleocapsid Protein (D63G, R203M, D377Y), His Tag can bind with SARS-CoV-2 Nucleocapsid Antibody (N338), mAb, mouse (Cat. No. A02135) in functional ELISA assay.
Expression System E.coli
Theoretical Molecular Weight 46.4 kDa
Apparent Molecular Weight ~47 kDa, on SDS-PAGE under reducing conditions.
Formulation Supplied as a solution of 50 mM Tris-HCl, 150 mM NaCl, pH 8.0, containing 300 mM Imidazole
Concentration Please refer to the COA for the specific lot
Storage & Stability Upon receiving, the product remains stable up to 6 months at -20 °C or below. Please avoid repeated freeze-thaw cycles

Examples
  • SARS-CoV-2 Nucleocapsid Protein (D63G, R203M, D377Y), His Tag
    • SARS-CoV-2 Nucleocapsid Protein (D63G, R203M, D377Y), His Tag

    Lane R: 2 μg of SARS-CoV-2 Nucleocapsid Protein (D63G, R203M, D377Y), His Tag, reducing(R)
    > 90% as analyzed by SDS-PAGE

  • SARS-CoV-2 Nucleocapsid Protein (D63G, R203M, D377Y), His Tag
    • SARS-CoV-2 Nucleocapsid Protein (D63G, R203M, D377Y), His Tag

    ELISA binding of SARS-CoV-2 Nucleocapsid Antibody (N338), mAb, mouse (GenScript, A02135) with SARS-CoV-2 Nucleocapsid Protein (D63G, R203M, D377Y), His Tag (GenScript, Z03732)

    Coating antigen:
    SARS-CoV-2 Nucleocapsid Protein (D63G, R203M, D377Y), His Tag (GenScript, Z03732), 1 μg/mL

    SARS-CoV-2 Nucleocapsid Antibody (N338), mAb, mouse (GenScript, A02135) dilution start from 2 μg/ml


Background
Target Background SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2), also known as 2019-nCoV, is a positive-sense single-stranded RNA virus. It caused coronavirus disease 2019 (COVID-19). Nucleocapsid Protein is the most abundant structural protein of the coronavirus which is associated with the nucleic acid. The sublineage B.1.617.2 has been redesignated as a "variant of concern" (VOC-21APR-02) in May 2021, which spreads more quickly than the original version of the virus.
Synonyms Lineage B.1.617.2; VUI-21APR-02; variant Delta
References 1. Tracking SARS-CoV-2 variants.
2. What You Need to Know About the Delta Variant. 

For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.